Prelude Therapeutics Inc(PRLD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PRLD Prelude Therapeutics Inc

盘后交易 01-06 18:29:03 EST

1.33

-0.06

-4.32%

盘后1.28

-0.05-3.76%

16:59 EST

最高1.43	最低1.29	成交量27.08万
今开1.38	昨收1.39	日振幅10.43%
总市值7,320万	流通市值1,850万	总股本5,504万
成交额36.08万	换手率1.95%	流通股本1,391万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PRLD","market":"US","secType":"STK","nameCN":"Prelude Therapeutics Inc","latestPrice":1.33,"timestamp":1736197200000,"preClose":1.39,"halted":0,"volume":270812,"hourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.33,"latestTime":"16:59 EST","volume":2652,"amount":3529.7597556,"timestamp":1736200744316},"delay":0,"floatShares":13910700,"shares":55035170,"eps":-1.772308,"marketStatus":"盘后交易","change":-0.06,"latestTime":"01-06 18:29:03 EST","open":1.38,"high":1.43,"low":1.285,"amount":360796.3010308,"amplitude":0.104317,"askPrice":1.39,"askSize":63,"bidPrice":1.24,"bidSize":67,"shortable":3,"etf":0,"ttmEps":-1.772308,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1736211600000},"marketStatusCode":4,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":1.39,"preHourTrading":{"tag":"盘前","latestPrice":1.38,"preClose":1.39,"latestTime":"08:53 EST","volume":61,"amount":84.78000209999999,"timestamp":1736171610882},"postHourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.33,"latestTime":"16:59 EST","volume":2652,"amount":3529.7597556,"timestamp":1736200744316},"volumeRatio":0.49286,"impliedVol":0.7498,"impliedVolPercentile":0.0996},"requestUrl":"/m/hq/s/PRLD/wiki","defaultTab":"wiki","newsList":[{"id":"2501254053","title":"Prelude Therapeutics Incorporated盘中异动 早盘大幅下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501254053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501254053?lang=zh_cn&edition=full","pubTime":"2025-01-06 23:35","pubTimestamp":1736177745,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时35分，Prelude Therapeutics Incorporated股票出现波动，股价大幅下挫5.04%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.40%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106233545aba0977f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106233545aba0977f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2500112658","title":"Prelude Therapeutics Incorporated盘中异动 早盘股价大涨10.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500112658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500112658?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:31","pubTimestamp":1735914716,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时31分，Prelude Therapeutics Incorporated股票出现异动，股价快速上涨10.40%。截至发稿，该股报1.38美元/股，成交量2.3255万股，换手率0.04%，振幅1.60%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.23%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223156a21468df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223156a21468df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","PRLD","LENZ"],"gpt_icon":0},{"id":"2500173909","title":"Prelude Therapeutics Incorporated盘中异动 下午盘股价大跌5.10%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500173909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500173909?lang=zh_cn&edition=full","pubTime":"2025-01-03 03:11","pubTimestamp":1735845088,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日03时11分，Prelude Therapeutics Incorporated股票出现异动，股价快速下挫5.10%。截至发稿，该股报1.21美元/股，成交量24.2658万股，换手率0.44%，振幅6.04%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.28%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103031128ab9c3075&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103031128ab9c3075&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","PRLD","LENZ"],"gpt_icon":0},{"id":"2495611596","title":"Prelude Therapeutics Incorporated盘中异动 早盘快速上涨7.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495611596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495611596?lang=zh_cn&edition=full","pubTime":"2024-12-31 23:14","pubTimestamp":1735658048,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日23时14分，Prelude Therapeutics Incorporated股票出现波动，股价急速拉升7.44%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.39%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123123140898569a91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123123140898569a91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","PRLD","BK4139","LENZ"],"gpt_icon":0},{"id":"2495401525","title":"Prelude Therapeutics Incorporated盘中异动 急速下挫5.22%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495401525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495401525?lang=zh_cn&edition=full","pubTime":"2024-12-30 22:41","pubTimestamp":1735569697,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日22时41分，Prelude Therapeutics Incorporated股票出现异动，股价急速下挫5.22%。截至发稿，该股报1.27美元/股，成交量1.5361万股，换手率0.03%，振幅5.78%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为1.02%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230224137ab982897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230224137ab982897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRLD","BK4505","BK4139"],"gpt_icon":0},{"id":"2494381812","title":"Prelude Therapeutics Incorporated盘中异动 早盘急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494381812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494381812?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:56","pubTimestamp":1735311400,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时56分，Prelude Therapeutics Incorporated股票出现异动，股价大幅拉升5.00%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.32%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227225640a20c03bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227225640a20c03bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2494865236","title":"Prelude Therapeutics Incorporated盘中异动 股价大涨9.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494865236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494865236?lang=zh_cn&edition=full","pubTime":"2024-12-26 22:31","pubTimestamp":1735223478,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日22时31分，Prelude Therapeutics Incorporated股票出现波动，股价大幅上涨9.24%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.40%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226223118a20a93c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226223118a20a93c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","PRLD","BK4139","LENZ"],"gpt_icon":0},{"id":"2493808773","title":"Prelude Therapeutics Incorporated盘中异动 早盘大幅下跌6.32%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493808773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493808773?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:39","pubTimestamp":1735051194,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时39分，Prelude Therapeutics Incorporated股票出现波动，股价急速下挫6.32%。截至发稿，该股报1.16美元/股，成交量2.0251万股，换手率0.04%，振幅4.44%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.46%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122422395495eb268a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122422395495eb268a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2493765103","title":"Prelude Therapeutics Incorporated盘中异动 早盘急速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493765103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493765103?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:35","pubTimestamp":1734964515,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时35分，Prelude Therapeutics Incorporated股票出现异动，股价大幅上涨5.38%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.14%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223517a2050bab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223517a2050bab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","PRLD","BK4139","LENZ"],"gpt_icon":0},{"id":"2492150440","title":"Prelude Therapeutics Incorporated盘中异动 股价大涨5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492150440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492150440?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:32","pubTimestamp":1734705129,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时32分，Prelude Therapeutics Incorporated股票出现波动，股价快速上涨5.87%。截至发稿，该股报0.940美元/股，成交量4.3633万股，换手率0.08%，振幅1.98%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.20%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223209a1fe23fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223209a1fe23fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","PRLD","BK4139"],"gpt_icon":0},{"id":"2492171237","title":"Prelude Therapeutics Incorporated盘中异动 早盘股价大涨7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492171237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492171237?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:44","pubTimestamp":1734619497,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时44分，Prelude Therapeutics Incorporated股票出现异动，股价大幅上涨7.03%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为3.00%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224457a1fb5c5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224457a1fb5c5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2492418440","title":"Prelude Therapeutics Incorporated盘中异动 大幅上涨7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492418440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492418440?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:43","pubTimestamp":1734532997,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时43分，Prelude Therapeutics Incorporated股票出现波动，股价急速上涨7.09%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.10%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224317984cb2c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224317984cb2c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","PRLD","BK4139"],"gpt_icon":0},{"id":"2491269736","title":"Prelude Therapeutics Incorporated盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491269736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491269736?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:38","pubTimestamp":1734359922,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时38分，Prelude Therapeutics Incorporated股票出现波动，股价快速拉升5.00%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.46%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223842ab7c97a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223842ab7c97a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2491566783","title":"Prelude Therapeutics Incorporated盘中异动 下午盘股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491566783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491566783?lang=zh_cn&edition=full","pubTime":"2024-12-13 03:44","pubTimestamp":1734032677,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日03时44分，Prelude Therapeutics Incorporated股票出现异动，股价快速跳水5.32%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为1.22%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121303443795e94169&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121303443795e94169&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","PRLD","BK4139","LENZ"],"gpt_icon":0},{"id":"2490868932","title":"Prelude Therapeutics Incorporated盘中异动 急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490868932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490868932?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:32","pubTimestamp":1733927572,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时32分，Prelude Therapeutics Incorporated股票出现异动，股价快速跳水5.05%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.30%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223253ab6fcab1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223253ab6fcab1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4505","PRLD"],"gpt_icon":0},{"id":"2490041718","title":"Prelude Therapeutics Incorporated盘中异动 快速跳水5.83%报0.970美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490041718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490041718?lang=zh_cn&edition=full","pubTime":"2024-12-11 02:05","pubTimestamp":1733853938,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日02时05分，Prelude Therapeutics Incorporated股票出现波动，股价大幅下挫5.83%。截至发稿，该股报0.970美元/股，成交量29.3027万股，换手率0.53%，振幅9.71%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.89%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211020538ab6d52b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211020538ab6d52b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2490772550","title":"Prelude Therapeutics Incorporated盘中异动 早盘大幅拉升5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490772550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490772550?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:32","pubTimestamp":1733758376,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时32分，Prelude Therapeutics Incorporated股票出现异动，股价大幅上涨5.41%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.87%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209233256a1e0c933&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209233256a1e0c933&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2489232077","title":"Prelude Therapeutics Incorporated盘中异动 大幅上涨5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489232077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489232077?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:43","pubTimestamp":1733499786,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时43分，Prelude Therapeutics Incorporated股票出现波动，股价急速上涨5.72%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.61%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623430698e5e4d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623430698e5e4d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2488942349","title":"Prelude Therapeutics Incorporated盘中异动 股价大跌5.86%报0.989美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488942349","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488942349?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:48","pubTimestamp":1733240907,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时48分，Prelude Therapeutics Incorporated股票出现异动，股价急速下挫5.86%。截至发稿，该股报0.989美元/股，成交量6.9408万股，换手率0.13%，振幅5.71%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.49%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203234827abf31ff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203234827abf31ff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","PRLD","LENZ"],"gpt_icon":0},{"id":"2486879372","title":"Prelude Therapeutics Incorporated盘中异动 早盘快速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486879372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486879372?lang=zh_cn&edition=full","pubTime":"2024-11-28 00:01","pubTimestamp":1732723297,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日00时01分，Prelude Therapeutics Incorporated股票出现异动，股价快速拉升5.10%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.48%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128000137971a8ebd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128000137971a8ebd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRLD","BK4505","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.preludetx.com","stockEarnings":[{"period":"1week","weight":0.0373},{"period":"1month","weight":0.4632},{"period":"3month","weight":-0.305},{"period":"6month","weight":-0.6139},{"period":"1year","weight":-0.6313},{"period":"ytd","weight":0.0902}],"compareEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":-0.0259},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.2668},{"period":"ytd","weight":0.01}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prelude Therapeutics Incorporated于2016年2月5日在特拉华州成立，是一家临床阶段的精密肿瘤学公司，致力于发现和开发针对高度未满足需求的癌症的关键驱动机制进行优化的小分子疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.076003},{"month":2,"riseRate":0.25,"avgChangeRate":0.011752},{"month":3,"riseRate":0.5,"avgChangeRate":-0.103502},{"month":4,"riseRate":0.25,"avgChangeRate":-0.112427},{"month":5,"riseRate":0.25,"avgChangeRate":-0.090292},{"month":6,"riseRate":0.25,"avgChangeRate":-0.034358},{"month":7,"riseRate":0.5,"avgChangeRate":0.154441},{"month":8,"riseRate":0.5,"avgChangeRate":0.081053},{"month":9,"riseRate":0,"avgChangeRate":-0.244964},{"month":10,"riseRate":0.4,"avgChangeRate":-0.225887},{"month":11,"riseRate":0.4,"avgChangeRate":0.220883},{"month":12,"riseRate":0.6,"avgChangeRate":0.134246}],"exchange":"NASDAQ","name":"Prelude Therapeutics Inc","nameEN":"Prelude Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Prelude Therapeutics Inc(PRLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Prelude Therapeutics Inc(PRLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Prelude Therapeutics Inc,PRLD,Prelude Therapeutics Inc股票,Prelude Therapeutics Inc股票老虎,Prelude Therapeutics Inc股票老虎国际,Prelude Therapeutics Inc行情,Prelude Therapeutics Inc股票行情,Prelude Therapeutics Inc股价,Prelude Therapeutics Inc股市,Prelude Therapeutics Inc股票价格,Prelude Therapeutics Inc股票交易,Prelude Therapeutics Inc股票购买,Prelude Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Prelude Therapeutics Inc(PRLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Prelude Therapeutics Inc(PRLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}